Scleroderma Treatment With Celution Processed ADRCs Registry

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (ADRCs) Registry

This registry study will assess the safety and performance of the Celution Device in the processing of an autologous graft consisting of adipose derived regenerative cells (ADRCs) in the treatment of hand scleroderma.

This registry study will assess the safety and performance of the Celution System in preparation of adipose derived regenerative cells in the treatment of scleroderma affecting the hands. This will be a multi-center, multi-national study.

Inclusion Criteria:

• Diagnosis of scleroderma and presence of hand scleroderma
• Cochin score ≥ 20 units

Exclusion Criteria:

• Body Mass Index < 17 kg/m2
• Infection in any finger
• Stable medications for the treatment of scleroderma for ≥ 1 month
• Pregnant or lactating status.